Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β3-adrenoceptor activation and α1-adrenoceptor blockade-Reference-Cited by-同舟云学术

Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β3-adrenoceptor activation and α1-adrenoceptor blockade

Published:2016-01-15 Issue:3 Volume:173 Page:415-428
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Alexandre E C¹,Kiguti L R²,Calmasini F B¹,Silva F H¹,da Silva K P²,Ferreira R³,Ribeiro C A²,Mónica F Z¹,Pupo A S²,Antunes E¹

Affiliation:

1. Department of Pharmacology; University of Campinas (UNICAMP); Campinas Brazil

2. Department of Pharmacology; Institute of Biosciences, University of São Paulo State (UNESP); Botucatu São Paulo Brazil

3. Hematology and Hemotherapy Center, Faculty of Medical Sciences; University of Campinas (UNICAMP); Campinas Brazil

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13367/fullpdf

Reference64 articles.

1. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen;Aboud;Br J Pharmacol,1993

2. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society;Abrams;NeurourolUrodyn,2002

3. Evaluation and treatment of lower urinary tract symptoms in older men;Abrams;J Urol,2013

4. Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770;Alexandre;J Pharmacol Exp Ther,2014

5. The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors;Alexander;Br J Pharmacol,2013a

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mirabegron 50 mg once daily, long-term treatment maximizes benefit in middle-aged and older people with overactive bladder syndrome: a systematic review and meta-analysis of nine phase II/III, randomized, double-blind, parallel-design, placebo-controlled, multicenter, and multinational trials;Frontiers in Surgery;2024-08-26

2. Dynamic phenotypic shifts and M2 receptor downregulation in bladder smooth muscle cells induced by mirabegron;Frontiers in Pharmacology;2024-07-24

3. Ligand–Receptor Interactions and Structure–Function Relationships in Off-Target Binding of the β3-Adrenergic Agonist Mirabegron to α1A-Adrenergic Receptors;International Journal of Molecular Sciences;2024-07-07

4. Mirabegron Add-On Tamsulosin for Men with Overactive Bladder Symptoms: A Pooled Analysis of Four Randomized Controlled Trials;Urologia Internationalis;2024

5. Is the β3-Adrenoceptor a Valid Target for the Treatment of Obesity and/or Type 2 Diabetes?;Biomolecules;2023-11-28